Intas Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is FINGOLIMOD HYDROCHLORIDE (FORM 1), with a corresponding US DMF Number 28387.
Remarkably, this DMF maintains an Active status since its submission on June 24, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 28, 2014, and payment made on June 18, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II